Fortrea Holdings Inc. (FTRE) News
Track canonical SquawkNews coverage tagged to FTRE, Fortrea Holdings Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 16 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Fortrea grants inducement RSUs and PSUs to five employees
Fortrea announced the granting of an inducement award of restricted stock units and performance share units on September 10, 2026, to five employees, under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 10, 2026, 09:11 PM UTC
L
Fortrea grants inducement awards under Nasdaq Rule 5635(c)(4)
EQUITY | Sep 10, 2026, 09:08 PM UTC
L
Fortrea to Participate in September Investor Conferences
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea NASDAQ:FTRE, a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations,
EQUITY | Sep 10, 2026, 01:01 PM UTC
L
FTRE - Fortrea to Participate in September Investor Conferences
FTRE - Fortrea to Participate in September Investor Conferences
EQUITY | Sep 10, 2026, 12:58 PM UTC
L
Fortrea reinstates Jason Knoblauch as chief financial officer
Fortrea reinstated Jason Knoblauch as chief financial officer following a legal dispute with his former employer. Knoblauch joined the contract-research company in July and was placed on a paid leave of absence later tha
EQUITY | Sep 10, 2026, 12:13 PM UTC
L
Fortrea reinstates Jason Knoblauch as CFO on Sept. 9, 2026
Fortrea Holdings Inc filed that Jason Knoblauch is reinstated as chief financial officer effective September 9, 2026, according to a referenced SEC filing.
EQUITY | Sep 10, 2026, 11:14 AM UTC
M
Fortrea reinstates Jason Knoblauch as CFO
Fortrea reinstated Jason Knoblauch as chief financial officer and principal financial officer. David Smith stepped down as interim CFO and remains on the board.
EQUITY | Sep 10, 2026, 11:03 AM UTC
M
Fortrea stock jumps after agreed acquisition of WCT Early Phase Services
Fortrea Holdings shares rose about 3% in the afternoon after the company agreed to acquire the Early Phase Services division of Worldwide Clinical Trials, per an official company press release.
MNA | Sep 02, 2026, 05:39 PM UTC
M
FTRE to acquire clinical pharmacology unit and bioanalytical lab operations
FTRE plans to acquire a clinical pharmacology unit and bioanalytical laboratory operations from Worldwide Clinical Trials.
MNA | Sep 02, 2026, 11:07 AM UTC
L
FTRE +5.3% on Revenue Forecast
FTRE jumps on strong revenue forecast
EARNINGS | Jul 29, 2026, 11:35 AM UTC
L
Fortrea Holdings Raises FY2026 Sales Guidance from $2.550B-$2.650B to $2.620B-$2.690B vs $2.607B Est
Fortrea Holdings (NASDAQ: FTRE ) raises FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.620 billion-$2.690 billion vs $2.607 billion estimate.
EARNINGS | Jul 29, 2026, 10:30 AM UTC
L
FTRE - Fortrea Reports Second Quarter 2026 Results
FTRE - Fortrea Reports Second Quarter 2026 Results
EARNINGS | Jul 29, 2026, 10:30 AM UTC
M
FTRE Reiterates FY26 Guidance
Fortrea reiterates FY26 guidance, targeting revenues of $2.550B-$2.650B and adjusted EBITDA of $190M-$220M
EARNINGS | Jun 26, 2026, 11:09 AM UTC
L
FTRE Names CFO
Fortrea names Jason Knoblauch as Chief Financial Officer, succeeding Jill McConnell
EQUITY | Jun 26, 2026, 11:00 AM UTC
M
Analysts Raise Targets
Top Wall Street analysts raise price targets for several stocks including Okta, International Seaways, and Ralliant
EQUITY | Jun 24, 2026, 01:00 PM UTC
M
FTRE: PT Raised
Barclays raises FTRE price target to $18 from $16
EQUITY | Jun 24, 2026, 09:45 AM UTC